All4liver is the name of Gilead’s fellowship program under the slogan “Diagnostics.” derived. Prioritize’. The program is designed to support innovative projects that advance diagnostics, improve linkages to healthcare, and help prioritize approaches to viral hepatitis on the public health agenda. All4liver will support all over the world (excluding USA) for Hepatitis C, B, or D.
Organizations wishing to participate can submit funding requests online by Gilead Grants Portal Before September 30, 2023. From then on, applications will be reviewed by an international committee of independent experts in the field of viral hepatitis.
public health threat
In 2016, World Health Organization The World Health Organization (WHO) has set a goal of eliminating viral hepatitis as a public health threat by 2030. With only seven years to go until this goal is achieved, a global approach in all areas related to viral hepatitis is urgently needed.
“The disruption caused by the COVID-19 pandemic has been profound,” said Danjuma Kamlen Adda, president of the World Hepatitis Alliance.
“expand Gilead Scholarship Program It reflects our commitment to addressing the urgent global challenge of viral hepatitis and creating a healthier future for all people living with liver disease. said Alex Kalomparis, senior vice president of scientific public affairs at Gilead.
Initially launched in the Asia-Pacific region in 2021, the All4liver Scholarship has provided more than US$1 million in funding to support initiatives to improve viral hepatitis education, with a focus on chronic hepatitis B in the region.